People: Thoratec Corp (THOR.OQ)

THOR.OQ on NASDAQ Stock Exchange Global Select Market

1:54pm EDT
Change (% chg)

$0.17 (+0.27%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Grossman, D. Keith 

Mr. D. Keith Grossman has been appointed as President, Chief Executive Officer, Director of Thoratec Corporation since September 2014. Mr. Grossman has served as a director of our Company since February 1996. From December 2011 until its sale to Bayer Healthcare in September 2013, Mr. Grossman served as President and Chief Executive Officer and a director of Conceptus, Inc., a women's health medical device company. From September 2007 to December 2011, Mr. Grossman served as a Managing Director with TPG (Texas Pacific Group), a private equity firm, in their healthcare investment team. From January 1996 until January 2006, Mr. Grossman served as our President and Chief Executive Officer. Prior to joining us, Mr. Grossman was a Division President of Major Pharmaceuticals, Inc., a pharmaceutical distributor, from June 1992 to September 1995, at which time it was sold. From July 1988 to June 1992, Mr. Grossman served as the Vice President of Sales and Marketing for Calcitek, Inc., a manufacturer of implantable medical devices and a division of Sulzermedica (formerly Intermedics, Inc.). Prior to 1988, Mr. Grossman held various other sales and marketing management positions within the McGaw Laboratories Division of American Hospital Supply Corporation. Mr. Grossman serves as a member of the board of directors of ZELTIQ Aesthetics, Inc. and has served as a member of the board of directors of Intuitive Surgical, Inc. within the last five years.

Basic Compensation

Total Annual Compensation, USD 391,786
Restricted Stock Awards, USD 10,095,000
Long-Term Incentive Plans, USD --
All Other, USD 43,419
Fiscal Year Total, USD 10,530,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Neil Dimick


Taylor Harris


Marta Antonucci


Niamh Pellegrini


David Lehman


Vasant Padmanabhan

As Of  30 Dec 2014
Search Stocks